HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain(RM1 Clinical Trial Optional) | RFA NS 22 069

Opportunity Information: Apply for RFA NS 22 069

The HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain (RM1 Clinical Trial Optional) funding opportunity (RFA-NS-22-069) is a National Institutes of Health (NIH) grant solicitation aimed at supporting ambitious, tightly coordinated team science in pain research. Its central purpose is to accelerate major advances in understanding the biology of human pain by integrating basic and clinical approaches in a way that a single laboratory or traditional single-PI project typically cannot. The FOA is positioned within the broader HEAL (Helping to End Addiction Long-term) Initiative context, emphasizing research that can meaningfully improve how pain is understood, stratified, and ultimately managed.

A defining feature of this opportunity is its required multi-PI structure: applications must be led by a team of three or more Program Directors/Principal Investigators (PDs/PIs), up to a maximum of six. The expectation is not simply that multiple leaders contribute separate pieces, but that the team functions as an integrated unit with real collaboration, deliberate coordination, and clear scientific synergy. NIH is explicitly signaling that it does not want a bundle of loosely connected projects or parallel workstreams. Instead, the application must present one cohesive, well-integrated research plan with a single overarching focus, one unified set of specific aims, and a consolidated budget that does not break into subprojects. In practical terms, the proposed science should be constructed so that the major questions can only be answered through coordinated team interactions, shared frameworks, and cross-disciplinary methods, rather than through independent efforts that happen to share a topic area.

Scientifically, the FOA supports research across both basic and clinical pain domains, with an emphasis on understanding the biology of specific human pain conditions as well as pain associated with a wide range of diseases and disorders. A major priority is tackling heterogeneity in pain: why patients with the same diagnosis can experience pain differently, respond differently to treatments, or follow different trajectories over time. The announcement highlights the importance of mechanistic underpinnings of that heterogeneity and encourages approaches that enable patient stratification, including consideration of co-morbidities that frequently complicate pain conditions. The overarching idea is to move beyond one-size-fits-all models of pain and toward biologically informed categories, mechanisms, and markers that can guide more precise clinical strategies.

Methodologically, the FOA calls for interdisciplinary research teams that can develop and apply new principles and methods for experimentation, analysis, and interpretation. That often implies combining complementary strengths such as clinical phenotyping, computational or statistical modeling, mechanistic biology, neurobiology, imaging, omics, biomarker discovery, behavioral science, and other relevant disciplines depending on the pain condition and scientific premise. The emphasis on developing new approaches is a signal that incremental or conventional designs may be less competitive than work that proposes genuinely enabling tools, platforms, datasets, analytic frameworks, or integrative experimental strategies that push the field forward.

The program also stresses a forward-looking, outcome-oriented mindset. Teams are encouraged to propose transformative objectives with clearly defined five-year outcomes, meaning the work should be planned around concrete deliverables and advances that are plausible within the project period. The intended impact is not just academic knowledge, but advances that are likely to improve strategies for effective management of human pain, whether through better mechanistic understanding, improved patient stratification, identification of actionable targets, or development of evidence that can inform clinical decision-making. The FOA is labeled “Clinical Trial Optional,” indicating that a clinical trial may be included if scientifically appropriate, but it is not required for all applications.

Eligibility is broad and spans many organization types, reflecting NIH’s interest in attracting diverse teams and institutional settings. Eligible applicants include various levels of government (state, county, city/township, and special districts), independent school districts, public and private institutions of higher education, nonprofit organizations (both 501(c)(3) and non-501(c)(3)), for-profit organizations (other than small businesses), and small businesses. The FOA also explicitly highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), certain tribal governments and tribal organizations, faith-based or community-based organizations, eligible federal agencies, U.S. territories or possessions, and non-U.S. entities (foreign organizations) as well as regional organizations. This breadth supports the formation of multi-institutional, multidisciplinary collaborations and encourages participation from a wide range of research communities.

Key administrative details from the source include the sponsoring agency (National Institutes of Health), the funding instrument (grant), the opportunity category (discretionary), and the closing date listed as February 13, 2024. The opportunity is associated with multiple CFDA numbers, reflecting the multi-institute and multi-program nature of NIH’s HEAL-related pain research funding. The award ceiling and expected number of awards are not specified in the provided listing, which typically means applicants should consult the full FOA text and NIH guidance for budget expectations, project period norms, and any institute-specific considerations.

Overall, this FOA is best understood as a team-science mechanism intended for research groups that can truly integrate basic and clinical pain research into one unified plan, aimed at explaining and predicting real-world variability in human pain and translating that understanding into better paths for pain management. The competitive applications will be those that demonstrate genuine interdependence among PDs/PIs, a clear and singular scientific vision, and a credible plan to deliver major advances within a defined five-year window.

• The National Institutes of Health in the education, health, income security and social services sector is offering a public funding opportunity titled "HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain(RM1 Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121, 93.233, 93.273, 93.393, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.865, 93.866.
• This funding opportunity was created on 2022-11-04.
• Applicants must submit their applications by 2024-02-13. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA NS 22 069

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: